NURS FPX 4055 Assessment 4: Health Promotion Plan Presentation
Good morning, everyone and welcome to this health promotion session. Our target audience is adolescents and young adults between the age of 11 and 26 in Schwenksville, Pennsylvania, to prevent HPV. This NURS FPX 4055 Assessment 4 will give us an overview of HPV, its association with certain cancerous conditions, the advantages of early HPV vaccination, and how to best formulate an effective message about the HPV vaccine to the health care provider and family members. SMART goals guide the session and are aligned with Healthy People 2030 objectives to ensure an overall targeted-outcome nature.
Presentation Overview
The program starts with the essential facts about HPV, how it is transmitted, and its linkage with different cancers, which is covered in the health promotion plan presentation. We will next discuss the safety and efficacy of the HPV vaccine and seek out the participants to consider taking it within 30 days. Another priority is the development of confidence to talk about the vaccine with the medical staff and family members. Interactive activities will solidify what was learned, and durability will be assessed by use of a post-presentation quiz and survey, as outlined in NURS FPX 4055 Assessment 4.
Key Facts About HPV and Cancer Risk
HPV is a widespread virus that is passed on majorly through sexual intercourse and skin-to-skin contact, which can be addressed through health promotion plan examples. In Pennsylvania, full vaccination against HPV in adolescents remains as low as 68.7 percentage, with the lowest rates in the rural population of Schwenksville (48.7%) (PA.gov, 2025). HPV is one of the major causes of various cancers among them being cervical, oropharyngeal, anal, and genital cancer. High-risk strains including HPV 16 and 18 cannot be detected by the body, thereby leading to cell abnormalities and cancer in the long run. Most of the infections are
discussed as being resolved without any intervention, but some continue to create severe health outcomes, highlighting the need for health promotion ideas for communities. Vaccination and not infrequent screenings play a crucial role as prevention, which is emphasized in NURS FPX 4055 Assessment 4.
Benefits of Timely HPV Vaccination
It is ideal to inoculate against the HPV virus at the age of 11 or 12 years when the immune system may build up strong and lasting protection before possible exposure, as emphasized in the health promotion plan presentation. This schedule makes the most use of vaccines to avert HPV-related illnesses (Hoes et al., 2021). Vaccination on time can considerably decrease the risk of cervical cancer one of the most common cancers in women all over the world, as well as of penile, anal, and oropharynx cancers (Cheng et al., 2020). The vaccine also guards against genital warts, which eliminates emotional suffering and stigma, a key point highlighted in NURS FPX 4055 Assessment 4. Also, early vaccination helps in creating herd immunity as a whole which decreases transmission of the virus and protects those who are vulnerable to it (Xu et al., 2024).
Communication Strategies for HPV Vaccination
The communication concerning HPV vaccination must be evidence-based and must respect everyone, serving as health promotion plan examples. To present the facts about vaccine safety and efficiency reliable sources, i.e. CDC and WHO should be utilized. It is advisable to ask well-informed questions regarding the long-term benefits of the vaccine and develop discussion (Kassymbekova et al., 2023). It is also important to end the misconceptions, such as explaining that receipt of HPV vaccination does not encourage the initiation of early sexual activity but instead helps prevent disease, as addressed in NURS FPX 4055 Assessment 4.
SMART Goals for the Session
Three SMART goals were used in this session.
- Knowledge- At least 90 percent of the participants will meet three correct facts related to HPV and its cancer association, as evaluated by a post-session exam.
- Commitment- The participation will make a commitment to schedule the first HPV vaccine dose within 30 days.
- Confidence – At least 85 percent of individuals will say they feel more confident talking to providers and family about the vaccine.
The upcoming sessions could combine family involvement and role plays to enhance relationship building.
Evaluation of SMART Goal Outcomes
Two of the SMART goals were achieved. The knowledge objective was attained successfully as 92.5 percent of the study participants reported being able to identify at least three correct facts about HPV. The confidence measure was achieved, as 85 percent of the participants were easier with talking about the vaccine. Just 75 percent promised to book the jab, a little below the 80 percent mark. Some of the participants indicated that they would like to consult the family to make a decision, and others exhibited reluctance to deal with vaccine myths, which is an important consideration in NURS FPX 4055 Assessment 4. Family treatment may be incorporated into subsequent visits through role play to improve communication techniques.
Alignment With Healthy People 2030 Objectives
“This session will help achieve the Healthy People 2030 goal of increasing vaccination rates against HPV among adolescents and demonstrates health promotion ideas for communities. The program increased awareness, added knowledge on vaccines, and promoted
prevention of health. Although vaccine commitment was not satisfying compared to the target, the progress shows that the strategies work, yet need additional refinements to counter hesitancy. The inclusion of myth-busting solutions, family-oriented conversations, and post-visit outreach will also assist in boosting uptake, as emphasized in NURS FPX 4055 Assessment 4.Conclusion
This health promotion session was important because it also highlighted the importance of getting vaccinated against HPV early to prevent cancer and protect the lives of the people living in the Schwenksville region, as discussed in NURS FPX 4055 Assessment 4. The program was quite successful in education and confidence building but showed signs that needed further modification, namely vaccine commitment, as highlighted in the health promotion plan presentation. Community involvement and evidence-based practices can help the community inch toward achieving goals laid out in the Healthy People 2030 and in the creation of a healthier generation of adolescents and young adults.
Summary Table
| Key Focus Area | Details | Impact/Outcome |
| HPV Facts & Risks | HPV is a sexual infection; associated with cervical cancer, anal cancer, genital and throat cancer. The low-vaccination rates (48.7%) are in rural areas such as Schwenksville. | Reduced cancer incidence by prevention of HPV was achieved through early detection and vaccination. |
| Vaccination Benefits | Vaccination at a younger age (11-12 years) produces a more robust immune response; prevents numerous cancers, as well as genital warts (Hoes et al., 2021; Cheng et al., 2020). | Decreases personal and societal risk, in favor of population health. |
| Communication & SMART Goals | Educational facts, informed inquiries, myth dispelling (Kassymbekova et al., 2023). The objectives were to gain knowledge, commitment and communication confidence. | Knowledge (92.5%) and confidence (85) objectives achieved; vaccine commitment (75) did not meet the mark; betterment to happen in the future. |
References
Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391
Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics, 18(1). https://doi.org/10.1080/21645515.2021.1908059
NURS FPX 4055 Assessment 4
Huber, J., Mueller, A., Sailer, M., & Regidor, P.-A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age: What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health, 17. https://doi.org/10.1177/17455065211028996
Kassymbekova, K., Abdukhakimova, A., Zhakipbekova, B., & Kurmangaliyev, A. (2023). Communication approaches in vaccination promotion. Health Promotion International, 38(1). https://doi.org/10.1093/heapro/daac112
U.S. Department of Health and Human Services. (n.d.). HPV vaccination: Healthy People 2030. https://health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/incr ease-hpv-vaccine-rates
Xu, Y., Liang, S., & Zhao, Q. (2024). Community herd immunity and HPV: Modeling impacts of adolescent vaccination. Public Health Reports, 139(2), 215–223. https://doi.org/10.1177/00333549231102378
